Looking to expand your partner network with leading companies like Nestlé Health Science? Consider joining Inpart's global network for free.
News and Trends 18 Jul 2022
Enterome and Nestlé Health Science to work on food allergies and inflammatory bowel disease
Enterome, a clinical stage biopharmaceutical company developing immunomodulatory drugs based on its bacterial Mimicry drug discovery platform, has signed a strategic R&D collaboration and license agreement with Nestlé Health Science targeting food allergies and inflammatory bowel disease (IBD). The collaboration aims to develop and commercialize Enterome’s lead EndoMimics pipeline candidate EB1010. EB1010 is a local […]
